341 related articles for article (PubMed ID: 29271213)
1. [Milk Thistle (Silybum Marianum) as a Supportive Phytotherapeutic Agent in Oncology].
Frassová Z; Rudá-Kučerová J
Klin Onkol; 2017; 30(6):426-432. PubMed ID: 29271213
[TBL] [Abstract][Full Text] [Related]
2. [Curcumine (Turmeric - Curcuma longa) as a Supportive Phytotherapeutic Treatment in Oncology].
Frassová Z; Rudá-Kučerová J
Klin Onkol; 2017; 31(1):15-23. PubMed ID: 29488773
[TBL] [Abstract][Full Text] [Related]
3. Clinical applications of Silybum marianum in oncology.
Greenlee H; Abascal K; Yarnell E; Ladas E
Integr Cancer Ther; 2007 Jun; 6(2):158-65. PubMed ID: 17548794
[TBL] [Abstract][Full Text] [Related]
4. A silychristin isomer and variation of flavonolignan levels in milk thistle (Silybum marianum) fruits.
Smith WA; Lauren DR; Burgess EJ; Perry NB; Martin RJ
Planta Med; 2005 Sep; 71(9):877-80. PubMed ID: 16206045
[TBL] [Abstract][Full Text] [Related]
5. A review of therapeutic potentials of milk thistle (
Emadi SA; Ghasemzadeh Rahbardar M; Mehri S; Hosseinzadeh H
Iran J Basic Med Sci; 2022 Oct; 25(10):1166-1176. PubMed ID: 36311193
[TBL] [Abstract][Full Text] [Related]
6. New therapeutic potentials of milk thistle (Silybum marianum).
Milić N; Milosević N; Suvajdzić L; Zarkov M; Abenavoli L
Nat Prod Commun; 2013 Dec; 8(12):1801-10. PubMed ID: 24555302
[TBL] [Abstract][Full Text] [Related]
7. Silybum marianum (milk thistle) and its main constituent, silymarin, as a potential therapeutic plant in metabolic syndrome: A review.
Tajmohammadi A; Razavi BM; Hosseinzadeh H
Phytother Res; 2018 Oct; 32(10):1933-1949. PubMed ID: 30015401
[TBL] [Abstract][Full Text] [Related]
8. Advances in the use of milk thistle (Silybum marianum).
Post-White J; Ladas EJ; Kelly KM
Integr Cancer Ther; 2007 Jun; 6(2):104-9. PubMed ID: 17548789
[TBL] [Abstract][Full Text] [Related]
9. Recent advances in the analysis of flavonolignans of Silybum marianum.
Csupor D; Csorba A; Hohmann J
J Pharm Biomed Anal; 2016 Oct; 130():301-317. PubMed ID: 27321822
[TBL] [Abstract][Full Text] [Related]
10. Milk thistle and the treatment of hepatitis.
Giese LA
Gastroenterol Nurs; 2001; 24(2):95-7. PubMed ID: 11847735
[TBL] [Abstract][Full Text] [Related]
11. Milk thistle (
Fanoudi S; Alavi MS; Karimi G; Hosseinzadeh H
Drug Chem Toxicol; 2020 May; 43(3):240-254. PubMed ID: 30033764
[TBL] [Abstract][Full Text] [Related]
12. Review of clinical trials evaluating safety and efficacy of milk thistle (Silybum marianum [L.] Gaertn.).
Tamayo C; Diamond S
Integr Cancer Ther; 2007 Jun; 6(2):146-57. PubMed ID: 17548793
[TBL] [Abstract][Full Text] [Related]
13. Milk thistle.
Rainone F
Am Fam Physician; 2005 Oct; 72(7):1285-8. PubMed ID: 16225032
[TBL] [Abstract][Full Text] [Related]
14.
Anwar S; Madkor HR; Ahmed N; Wagih ME
Indian J Pharmacol; 2018; 50(3):108-115. PubMed ID: 30166747
[TBL] [Abstract][Full Text] [Related]
15. The food plant Silybum marianum (L.) Gaertn.: Phytochemistry, Ethnopharmacology and clinical evidence.
Marmouzi I; Bouyahya A; Ezzat SM; El Jemli M; Kharbach M
J Ethnopharmacol; 2021 Jan; 265():113303. PubMed ID: 32877720
[TBL] [Abstract][Full Text] [Related]
16. Chemoprotective effect of plant phenolics against anthracycline-induced toxicity on rat cardiomyocytes. Part I. Silymarin and its flavonolignans.
Chlopcíková S; Psotová J; Miketová P; Simánek V
Phytother Res; 2004 Feb; 18(2):107-10. PubMed ID: 15022159
[TBL] [Abstract][Full Text] [Related]
17. Milk thistle: is there a role for its use as an adjunct therapy in patients with cancer?
Ladas EJ; Kelly KM
J Altern Complement Med; 2003 Jun; 9(3):411-6. PubMed ID: 12816629
[TBL] [Abstract][Full Text] [Related]
18. A review on the mechanisms of the effect of silymarin in milk thistle (Silybum marianum) on some laboratory animals.
Khazaei R; Seidavi A; Bouyeh M
Vet Med Sci; 2022 Jan; 8(1):289-301. PubMed ID: 34599793
[TBL] [Abstract][Full Text] [Related]
19. Silybin, a Major Bioactive Component of Milk Thistle (Silybum marianum L. Gaernt.)-Chemistry, Bioavailability, and Metabolism.
Bijak M
Molecules; 2017 Nov; 22(11):. PubMed ID: 29125572
[TBL] [Abstract][Full Text] [Related]
20. Poor chemical and microbiological quality of the commercial milk thistle-based dietary supplements may account for their reported unsatisfactory and non-reproducible clinical outcomes.
Fenclova M; Novakova A; Viktorova J; Jonatova P; Dzuman Z; Ruml T; Kren V; Hajslova J; Vitek L; Stranska-Zachariasova M
Sci Rep; 2019 Jul; 9(1):11118. PubMed ID: 31366891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
